Skip to main content

Advertisement

Log in

The Trend of Inflammatory Bowel Diseases in Taiwan: A Population-Based Study

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background and Aim

The purpose of this study was to estimate the sex- and age-specific incidence rates of inflammatory bowel diseases (IBD) in Taiwan. Site-specific cancer occurred in patients with IBD would be reported, too.

Methods

A retrospective study by analyzing the data from the National Health Insurance Research Database of Taiwan.

Results

Between 2000 and 2010, the overall incidence rate of Crohn’s disease (CD) and ulcerative colitis (UC) was 0.208 and 0.838 per 100,000 person-years. For male, the incidence rate of CD was 0.195 (95 % CI 0.113–0.276) per 100,000 persons in 2000 and increased to 0.318 (95 % CI 0.216–0.421) per 100,000 persons in 2010. For female, the incidence rate of CD was 0.092 (95 % CI 0.035–0.149) per 100,000 persons in 2000 and increased to 0.210 (95 % CI 0.128–0.293) per 100,000 persons in 2010. For male, the incidence rate of UC was 0.690 (95 % CI 0.537–0.843) per 100,000 persons in 2000 and increased to 1.351 (95 % CI, 1.140–1.562) per 100,000 persons in 2010. For female, the incidence rate of UC was 0.386 (95 % CI 0.269–0.503) per 100,000 persons in 2000 and increased to 0.858 (95 % CI 0.691–1.024) per 100,000 persons in 2010. Among the CD patients, 0.19 % had colorectal cancers (1/519). Among the UC patients, 0.24 % had colorectal cancers (5/2098).

Conclusions

This nationwide population-based longitudinal epidemiological study of IBD in Taiwan provides data for future global comparisons.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Abraham C, Cho Judy H. Inflammatory bowel disease. N Engl J Med. 2009;361:2066–2078.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Molodecky NA, Soon S, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time based on systematic review. Gastroenterology. 2012;142:46–54.

    Article  PubMed  Google Scholar 

  3. Economou M, Pappas G. New global map of Crohn’s disease: genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis. 2008;14:709–720.

    Article  PubMed  Google Scholar 

  4. Thia KT, Loftus E, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008;103:3167–3182.

    Article  PubMed  Google Scholar 

  5. Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol. 2012;27:1266–1280.

    Article  PubMed  Google Scholar 

  6. Kuo CFSL, Yu KH, Chou IJ, et al. Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol. 2011;40:373–378.

    Article  PubMed  Google Scholar 

  7. Chiang C-J, Chen YC, Chen C-J, You S-L, Lai M-S, Taiwan cancer registry task force. Cancer Trends in Taiwan. Jpn J Clin Oncol. 2010;40:897–904.

    Article  PubMed  Google Scholar 

  8. Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology study. Gastroenterology. 2013;145:158–165.

    Article  PubMed  Google Scholar 

  9. Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785–1794.

    Article  PubMed  Google Scholar 

  10. Gisbert JP, Chaparro M. Systematic review with meta-analysis: inflammatory bowel disease in the elderly. Alim Pharmacol Ther. 2014;39:459–477.

    Article  CAS  Google Scholar 

  11. Joannie R, Ruel CH, Charpentier C, Gower-Rousseau C, Colombel J-F. IBD in the elderly. Inflamm Bowel Dis Monit. 2013;14:1–11.

    Google Scholar 

  12. Ananthakrishnan ANBD. Treatment of ulcerative colitis in the elderly. Dig Dis. 2009;27:327–334.

    Article  PubMed  Google Scholar 

  13. Katz S, Pardi DS. Inflammatory bowel disease of the elderly: frequently asked questions. Am J Gastroenterol. 2011;106:1889–1897.

    Article  PubMed  Google Scholar 

  14. Herrinton LJLL, Levin TR, et al. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 2012;143:382–389.

    Article  PubMed  Google Scholar 

  15. Pedersen NDD, Elkjaer M, Gamborg M, Munkholm P, Jess T. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am J Gastroenterol. 2010;105:1480–1487.

    Article  PubMed  Google Scholar 

  16. Jess TRC, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012;10:639–645.

    Article  PubMed  Google Scholar 

  17. Ooi CJ, Fock KM, Makharia GK. The Asia-Pacific consensus on ulcerative colitis. J Gastroenterol Hepatol. 2010;25:453–468.

    Article  CAS  PubMed  Google Scholar 

  18. Katsanos KH, Pedersen N, Shuhaibar M, et al. Cancer in inflammatory bowel disease 15 years aft er diagnosis in a population-based European Collaborative follow-up study. J Crohns Colitis. 2011;5:430–442.

    Article  PubMed  Google Scholar 

  19. Kim BJYS, Kim JS, Jeen YT, et al. Trends of ulcerative colitis-associated colorectal cancer in Korea: a KASID study. J Gastroenterol Hepatol. 2009;24:667–671.

    Article  PubMed  Google Scholar 

  20. Wei S-C, Shieh MJ, Chang MC, Chang YT, Wang C-Y, Wong J-M. Long-term follow-up of ulcerative colitis in Taiwan. J Chin Med Assoc. 2012;75:151–155.

    Article  PubMed  Google Scholar 

  21. Rutter MD, Saunder BP, Wilkinson KH, et al. Thirty year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006;130:1030–1038.

    Article  PubMed  Google Scholar 

  22. Jess T, Horvath-Puho E, Fallingborg J, Rasmussen HH, Jacobsen BA. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a danish population-based cohort study. Am J Gastroenterol. 2013;108:1869–1876.

    Article  CAS  PubMed  Google Scholar 

  23. Long MD, Martin CF, Pipkin CA, Herfarth HH, Sandler RS, Kappelman MD. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology. 2012;143:390–399.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Jess T, Simensen J, Jørgensen KT, Pedersen BV, Nielsen NM, Frisch M. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology. 2012;143:375–381.

    Article  PubMed  Google Scholar 

  25. Kappelman MD, Farkas D, Long MD, et al. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation. Clin Gastroenterol Hepatol. 2014;12:265–273.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Zheng JJZX, Huangfu Z, Shi XH, Guo ZR. Prevalence and incidence rates of Crohn’s disease in mainland China: a meta-analysis of 55 years of research. J Dig Dis. 2010;11:161–166.

    Article  PubMed  Google Scholar 

  27. Asakura KNY, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn’s disease in Japan. J Gastroenterol. 2009;44:659–665.

    Article  PubMed  Google Scholar 

  28. Yao TMT, Hiwatashi N. Crohn’s disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum. 2000;43:S85–S93.

    Article  CAS  PubMed  Google Scholar 

  29. Yang SKYS, Kim JH, Park JY, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986–2005: a KASID study. Inflamm Bowel Dis. 2008;14:542–549.

    Article  PubMed  Google Scholar 

  30. Sood AMV, Sood N, Bhatia AS, Avasthi G. Incidence and prevalence of ulcerative colitis in Punjab. North India Gut. 2003;52:1587–1590.

    Article  CAS  Google Scholar 

  31. Lee YMFK, See SJ, Ng TM, Khor C, Teo EK. Racial differences in the prevalence of ulcerative colitis and Crohn’s disease in Singapore. J Gastroenterol Hepatol. 2000;15:622–625.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

CJ Kuo, KH Yu, CT Chiu, MY Su, CM Hsu, CF Kuo, and HW Wang developed the study concept and design and provided the critical revision of the manuscript for important intellectual content. LC See, MJ Chiou, and JR Liu collected and interpreted the data. All authors approved the final version of the manuscript.

Conflict of interest

The authors report no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cheng-Tang Chiu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kuo, CJ., Yu, KH., See, LC. et al. The Trend of Inflammatory Bowel Diseases in Taiwan: A Population-Based Study. Dig Dis Sci 60, 2454–2462 (2015). https://doi.org/10.1007/s10620-015-3630-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-015-3630-z

Keywords

Navigation